AL
MET icon

Aspiriant LLC’s MetLife MET Stock Holding History

Aspiriant LLC’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
2,482
-1,542
-38% -$124K 0.01% 379
2026
Q1 		$285K Buy
4,024
+599
+17% +$44.8K 0.01% 287
2025
Q4 		$270K Buy
3,425
+214
+7% +$16.9K 0.01% 287
2025
Q3 		$264K Sell
3,211
-655
-17% -$51.5K 0.01% 269
2025
Q2 		$311K Buy
3,866
+530
+16% +$40.9K 0.01% 247
2025
Q1 		$268K Buy
3,336
+115
+4% +$9.56K 0.01% 249
2024
Q4 		$264K Buy
3,221
+3
+0.1% +$250 0.01% 249
2024
Q3 		$265K Buy
3,218
+17
+0.5% +$1.27K 0.01% 249
2024
Q2 		$225K Sell
3,201
-1,095
-25% -$78.2K 0.01% 262
2024
Q1 		$318K Buy
4,296
+88
+2% +$6.13K 0.01% 238
2023
Q4 		$278K Buy
4,208
+95
+2% +$5.95K 0.01% 254
2023
Q3 		$259K Buy
4,113
+297
+8% +$18.5K 0.01% 241
2023
Q2 		$216K Sell
3,816
-26
-0.7% -$1.44K 0.01% 267
2023
Q1 		$223K Buy
3,842
+98
+3% +$6.61K 0.01% 259
2022
Q4 		$271K Buy
3,744
+243
+7% +$17.4K 0.01% 225
2022
Q3 		$213K Buy
3,501
+113
+3% +$7.22K 0.01% 243
2022
Q2 		$213K Buy
3,388
+42
+1% +$2.78K 0.01% 258
2022
Q1 		$235K Buy
+3,346
New +$226K 0.01% 251
2018
Q2 		– Sell
-4,600
Closed -$211K – 257
2018
Q1 		$211K Buy
+4,600
New +$223K 0.02% 226

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aspiriant LLC's MET Position: Q2 2026 in Review

Aspiriant LLC reduced its MetLife (MET) stake by 38% in Q2 2026, selling an estimated $124K and leaving 2,482 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #379.

Aspiriant LLC first reported a position in MET in Q1 2018 and has held it in 19 quarters since. The position peaked at $318K in Q1 2024. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Aspiriant LLC held 2,482 shares of MetLife worth $210K as of Q2 2026.
  • Aspiriant LLC sold 1,542 MetLife shares in Q2 2026, an estimated $124K.
  • MetLife made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #379 holding.
  • Aspiriant LLC first reported a position in MetLife in Q1 2018 and has held it in 19 quarters since.
  • Aspiriant LLC's MetLife position peaked at $318K in Q1 2024.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.